Inhibikase Therapeutics, Inc. (IKT) Institutional Ownership

Institutions by Trading Activity

90,050,973Shares Outstanding

115,067,593Shares held by institutions

$193,888,894Value of institutional holdings

127.78%Institutional ownership %

108.88%Shares Changed QoQ

73No. of institutional investors

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) showed up in the 13F filings of 73 institutional investors as of December 2025.

Collectively, these holders controlled 127.1% of Inhibikase Therapeutics's outstanding shares in December 2025, up from 61.1% in September 2025.
Their total shares held in IKT increased 108.08% from the prior quarter, while the number of investors in Inhibikase Therapeutics increased 128.12% year over year.
Of these 73 holders, 48 added to their stakes in Inhibikase Therapeutics, 15 trimmed positions, and 10 made no changes.
Combined, these investors held 114.45Mn shares in IKT for December 2025, up by 59.45Mn shares quarter on quarter, and up 64.35Mn shares year over year.
As of December 31, 2025, CCG WEALTH MANAGEMENT, LLC held the largest stake in Inhibikase Therapeutics with 24.12K shares, accounting for 0.03% of total shares outstanding.
The largest buyers of Inhibikase Therapeutics for the quarter ending December 2025 were CCG WEALTH MANAGEMENT, LLC (24.12K), SG Americas Securities, LLC (15.48K), U.S. Capital Wealth Advisors, LLC (10.0K), GAMMA Investing LLC (411), Farther Finance Advisors, LLC (69).
According to Business Quant data, leading holders of IKT for December 2025 are CCG WEALTH MANAGEMENT, LLC (24.12K), SG Americas Securities, LLC (15.48K), U.S. Capital Wealth Advisors, LLC (10.0K), Sterling Capital Management LLC (3.28K), GAMMA Investing LLC (411), Farther Finance Advisors, LLC (69), True Wealth Design, LLC (43), SJS Investment Consulting Inc. (9), IFP Advisors, Inc (3).

115,067,593 Total Shares Held

Rows:

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
ADAR1 Capital Management, LLC	31 Dec, 2025	16,127,898	10,880,295	207.34%	$33,062,190.00
Sands Capital Alternatives, LLC	31 Dec, 2025	13,018,965	0	0.00%	$21,871,861.00
Sands Capital Alternatives, LLC	31 Dec, 2025	13,018,965	2,068,965	18.89%	$26,688,878.00
Soleus Capital Management, L.P.	31 Dec, 2025	10,875,000	0	0.00%	$18,270,000.00
Soleus Capital Management, L.P.	31 Dec, 2025	10,875,000	4,550,000	71.94%	$22,293,750.00
Fairmount Funds Management LLC	31 Dec, 2025	8,625,000	2,500,000	40.82%	$17,681,250.00
Fairmount Funds Management LLC	31 Dec, 2025	8,625,000	0	0.00%	$14,490,000.00
Trails Edge Capital Partners, LP	31 Dec, 2025	8,057,345	1,879,221	30.42%	$13,536,340.00
ADAR1 Capital Management, LLC	31 Dec, 2025	6,606,572	-9,521,326	-59.04%	$11,099,041.00
BlackRock, Inc.	31 Dec, 2025	6,303,433	2,997,859	90.69%	$10,589,768.00
Trails Edge Capital Partners, LP	31 Dec, 2025	6,178,124	6,178,124	0.00%	$12,665,154.00
Blackstone Inc.	31 Dec, 2025	5,938,276	3,300,000	125.08%	$12,173,466.00
Blackstone Inc.	31 Dec, 2025	5,938,276	0	0.00%	$9,976,304.00
Siren, L.L.C.	31 Dec, 2025	5,850,000	5,850,000	0.00%	$11,992,500.00
Siren, L.L.C.	31 Dec, 2025	5,850,000	0	0.00%	$9,828,000.00
PERCEPTIVE ADVISORS LLC	31 Dec, 2025	5,421,568	0	0.00%	$11,114,214.00
Commodore Capital LP	31 Dec, 2025	5,397,488	0	0.00%	$11,064,850.00
Commodore Capital LP	31 Dec, 2025	5,397,488	0	0.00%	$9,067,780.00
VANGUARD GROUP INC	31 Dec, 2025	4,558,604	1,285,265	39.26%	$9,345,138.00
VANGUARD CAPITAL MANAGEMENT LLC	31 Dec, 2025	4,450,665	4,450,665	0.00%	$7,477,117.00

1 - 20 of 167